levofloxacin
- Product NDC
- 63187-514
- Requested package NDC
- 63187-514-15
- 11-digit product format
- 631870514
- Labeler code
- 63187
- Product ID
- 63187-514_2fb76e4a-2c83-4764-a399-ff7811f179c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levofloxacin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA077652
- Marketing category
- ANDA
- Marketing start
- 2012-11-10
- Marketing end
- 0000-00-00
- Substance
- LEVOFLOXACIN
- Active strength
- 750 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63187-514 | 63187-514-15 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077652-001 | LEVOFLOXACIN | LEVOFLOXACIN | 250MG | TABLET / ORAL | AB | 2012-09-07 | |
| A077652-002 | LEVOFLOXACIN | LEVOFLOXACIN | 500MG | TABLET / ORAL | AB | 2012-09-07 | |
| A077652-003 | LEVOFLOXACIN | LEVOFLOXACIN | 750MG | TABLET / ORAL | AB | 2012-09-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077652-001 | AB |
| A077652-002 | AB |
| A077652-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077652-001 | LEVOFLOXACIN | 250MG | TABLET / ORAL | AB | 2012-09-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077652-002 | LEVOFLOXACIN | 500MG | TABLET / ORAL | AB | 2012-09-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077652-003 | LEVOFLOXACIN | 750MG | TABLET / ORAL | AB | 2012-09-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077652-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077652-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077652-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| levofloxacin | LEVOFLOXACIN | Redpharm Drug | 5261da15-1b6c-fbe2-e063-6394a90ad85e | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Redpharm Drug | 44f31105-5fc9-43d4-e063-6294a90a510f | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | REMEDYREPACK INC. | 264a3f71-f23e-45e3-926a-421bcccf4e3d | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals Inc. | 7a12135e-cbad-4fe1-98f7-53c41d1f2a21 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Redpharm Drug | 301ecffc-ecaf-01de-e063-6294a90a61b3 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Bryant Ranch Prepack | cbd5153f-fada-4682-b858-dc3b6e3173cc | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Coupler LLC | 2cee61b7-be51-0fe5-e063-6294a90af9e3 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals Inc | 067e260c-dc47-4957-a9ff-5a79f17b4ca0 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Bryant Ranch Prepack | b7a614b0-f604-48e1-9919-21da8f939d93 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| levofloxacin | LEVOFLOXACIN | Zydus Lifesciences Limited | ffa121b8-388f-4d7b-af48-d4aa8d9b5961 | 2024-08-16 | 077652 ANDA077652 | |
| levofloxacin | LEVOFLOXACIN | Viona Pharmaceuticals Inc | 0948bff7-efc6-4f0e-a9dd-adca5bdc7fc2 | 2024-06-25 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
| Levofloxacin | LLEVOFLOXACIN | Advanced Rx Pharmacy of Tennessee, LLC | 19afbe98-484c-c980-e063-6294a90acdc6 | 2024-05-22 | Boxed warning, Warnings, Adverse reactions | 077652 ANDA077652 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63187-514-07 | EA - Each | 63187-514 | 5340dcbd-5e32-4c30-a52c-fd3d9afd42d3 | 1 | 2015-11-12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVOFLOXACIN | ACTIVE INGREDIENT | 6GNT3Y5LMF | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| LEVOFLOXACIN ANHYDROUS | ACTIVE MOIETY | RIX4E89Y14 | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| POLYETHYLENE GLYCOL 6000 | INACTIVE INGREDIENT | 30IQX730WE | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LEVOFLOXACIN TABLET, FILM COATED [PROFICIENT RX LP] | 1 |
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63187-514-15 | 63187051415 | 15 TABLET, FILM COATED in 1 BOTTLE (63187-514-15) | 2018-12-01 | 0000-00-00 | No | No | Current |